These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 796848)

  • 1. Response to shamsi, hina, akhtar, et al.
    Huang RS; Raman S
    J Natl Cancer Inst; 2024 May; ():. PubMed ID: 38718212
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs.
    Dworski M
    Am Rev Respir Dis; 1973 Aug; 108(2):294-300. PubMed ID: 4578541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of protective effect of killed and live BCG bacilli and INH-resistant tubercle bacilli in guinea pigs].
    Paklerska-Pobratyn H; Kostrzeński W
    Gruzlica; 1968 Jun; 36(6):509-16. PubMed ID: 4970098
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production and laboratory examination of INH-resistant BCG vaccine].
    Milinković M
    Plucne Bolesti Tuberk; 1971; 23(4):347-53. PubMed ID: 4948961
    [No Abstract]   [Full Text] [Related]  

  • 5. [Different pathogenic power of the original BCG strain of the Pasteur Institute and of an isoniazid resistant strain. Histopathological study and significance of local abscesses after inoculation of guinea pig].
    Levaditi JC; Baloquet G; Kosloff-Senechal ; Augier J; Augier S; Baret M
    Sem Hop; 1975 Apr; 51(17):1167-73. PubMed ID: 174202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. II. Field trial in man.
    Vandiviere HM; Dworski M; Melvin IG; Watson KA; Begley J
    Am Rev Respir Dis; 1973 Aug; 108(2):301-13. PubMed ID: 4578542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Obtaining active BCG substrains resistant to HINA].
    Gel'berg SI; Pozniak SB
    Probl Tuberk; 1976 Sep; (9):64-9. PubMed ID: 796848
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 9. Current approach to tuberculosis in childhood.
    Rosenberg M; Gottlieb RP
    Pediatr Clin North Am; 1968 May; 15(2):513-47. PubMed ID: 4872899
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.